IP Library › Assignment 058726/0499
Patent Assignment
Reel/Frame 058726/0499

Assignment of Assignor's Interest

Recorded: 2022-01-21 Pages: 4
Assignor
Assignee
CHARLES RIVER LABORATORIES, INC.
251 BALLARDVALE STREET, WILMINGTON, MASSACHUSETTS, 01887
Covered Property (1)
Plasma Kallikrein Inhibitors and Uses Thereof
Application: 17/024,437 →
Publication: US 2021/0078999
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 30, 2021
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055766/0572 →
Assignment of Assignor's Interest Jan 21, 2022
From: ELLARD, JOHN MARK; RAE, ALASTAIR
To: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
Reel/Frame 058726/0408 →
Assignment of Assignor's Interest Jan 21, 2022
From: PAPAIOANNOU, NIKOLAOS; TRAVINS, JEREMY MARK; FINK, SARAH JOCELYN
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058726/0446 →
Assignment of Assignor's Interest Jan 21, 2022
From: FINK, SARAH JOCELYN
To: BIODURO LLC
Reel/Frame 058726/0395 →
Assignment of Assignor's Interest Jan 21, 2022
From: CHARLES RIVER LABORATORIES, INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058726/0493 →
Assignment of Assignor's Interest Jan 21, 2022
From: BIODURO LLC
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058726/0476 →
Assignment of Assignor's Interest Mar 7, 2022
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 059185/0461 →